LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 106.96K shares, a 10.56% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 95.07K shares, a 67.72% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 114.93K shares, a 61.13% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 344.61K shares, a 7.09% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 635.82K shares, a 41.14% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 1.08M shares, a 120.85% increase from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 489.08K shares.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 619.73K shares, a 295.12% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 106.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 661.57K shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 95.07K shares 10-Q · filed 2026-05-08 | 674.21K shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | 114.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 635.82K shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 344.61K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 816.56K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | 119.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 793.75K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | 56.68K shares 10-Q · filed 2025-05-09 | 841.32K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | 295.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 1.08M shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 321.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 910.62K shares derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | 167.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | |
| 2024-03-31 | 295.50K shares 10-Q · filed 2024-05-08 | |
| 2023-12-31 | 126.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 489.08K shares 10-K · filed 2026-02-27 |
| 2021-12-31 | 619.73K shares 10-K · filed 2024-02-29 | |
| 2020-12-31 | 156.84K shares 10-K · filed 2023-02-28 | |
| 2019-12-31 | 112.01K shares 10-K · filed 2022-02-28 | |
| 2018-12-31 | 358.16K shares 10-K · filed 2021-02-24 | |
| 2018-06-30 | 55.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 256.38K shares derived: sum of 4 quarters · filed 2018-08-08 |
| 2018-03-31 | 133.80K shares 10-Q · filed 2018-05-09 | 252.64K shares derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | 27.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 148.25K shares 10-K · filed 2018-03-01 |
| 2017-09-30 | 39.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 155.08K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 51.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 168.07K shares derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | 29.41K shares 10-Q · filed 2017-05-09 | 149.82K shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | 34.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 164.44K shares 10-K · filed 2017-02-28 |
| 2016-09-30 | 52.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 159.56K shares derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-06-30 | 33.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | 191.31K shares derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-03-31 | 44.03K shares 10-Q · filed 2016-11-14 | 327.96K shares derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-12-31 | 29.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14 | 326.42K shares 10-K · filed 2016-11-14 |
| 2015-09-30 | 84.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 315.74K shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | 169.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | 259.94K shares derived: sum of 4 quarters · filed 2015-08-05 |
| 2015-03-31 | 42.49K shares 10-Q · filed 2015-05-11 | 120.07K shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 18.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | 281.51K shares 10-K · filed 2015-02-23 |
| 2014-09-30 | 28.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | 321.00K shares derived: sum of 4 quarters · filed 2014-12-12 |
| 2014-06-30 | 30.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | 379.11K shares derived: sum of 4 quarters · filed 2014-12-12 |
| 2014-03-31 | 203.93K shares 10-Q · filed 2014-05-07 | 397.60K shares derived: sum of 4 quarters · filed 2014-12-12 |
| 2013-12-31 | 58.18K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | 217.07K shares 10-K/A · filed 2014-12-12 |
| 2013-09-30 | 87.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | 198.68K shares derived: sum of 4 quarters · filed 2014-12-12 |
| 2013-06-30 | 48.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | 141.47K shares derived: sum of 4 quarters · filed 2014-12-12 |
| 2013-03-31 | 23.40K shares 10-Q · filed 2013-05-08 | |
| 2012-12-31 | 39.79K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | 86.59K shares 10-K/A · filed 2014-12-12 |
| 2012-09-30 | 29.80K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | |
| 2011-12-31 | 6.07K shares 10-K/A · filed 2014-12-12 |